TIGIT and neoplasm: TIGIT impacts adenosine receptor signaling in T-cells, interferes with T-cell energy metabolism, and is associated with the kynurenine pathway in tumor cells, thereby altering the TME and T-cell-mediated immunity against tumors (120).